API reference
Dolutegravir sodium
- CAS number
- 1051375-19-9
- Molecular formula
- C20H18F2N3NaO5
- Molecular weight
- 441.4 g/mol
About this molecule
Dolutegravir is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV in adults and children. Dolutegravir is approved under two different brand names: Tivicay and Tivicay PD. Tivicay and Tivicay PD are approved for use with other HIV medicines in adults and in children weighing at least 4.4 lb (2 kg) and who meet specific requirements, as determined by a health care provider. Tivicay is approved for use with rilpivirine (brand name: Edurant) as a complete regimen in adults who meet specific requirements, as determined by a health care provider. (A fixed-dose combination tablet containing dolutegravir and rilpivirine [brand name: Juluca] is also available.) Dolutegravir is always used in combination with other HIV medicines.
Source: Drug Database, Clinicalinfo.hiv.gov, via PubChem.
Identifiers
- IUPAC name
- sodium (3S,7R)-13-[(2,4-difluorophenyl)methylcarbamoyl]-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-olate
- InChIKey
- UGWJRRXTMKRYNK-VSLILLSYSA-M
- SMILES
- C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)[O-].[Na+]
- PubChem CID
- 46216142
Also known as
DOLUTEGRAVIR SODIUM · Dolutegravir sodium salt · TIVICAY PD · JULUCA COMPONENT DOLUTEGRAVIR SODIUM · TRIUMEQ COMPONENT DOLUTEGRAVIR SODIUM · Tivicay · Dolutegravir (sodium) · Dovato
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.